OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Olema Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$7.11+0.53 (+8.05%)
Close on Oct 19, 2026
- Market cap
- $742.67M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$178.70MFY2025